Member Publications - 2007

January

  1. Lung specific developmental expression of the Xenopus laevis surfactant protein C and B genes. Hyatt BA, Resnik ER, Johnson NS, Lohr JL, Cornfield DN. Gene Expr Patterns. 2007 Jan;7(1-2):8-14.

February

March

April

  1. Case-series of nurse-administered nitrous oxide for urinary catheterization in children. Zier JL, Drake GJ, McCormick PC, Clinch KM, Cornfield DN. Anesth Analg. 2007 Apr;104(4):876-9.

  2. Chronic intrauterine pulmonary hypertension increases capacitative calcium entry in fetal pulmonary artery smooth muscle cells. Resnik ER, Keck M, Sukovich DJ, Herron JM, Cornfield DN. Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L953-9.

  3. Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation. Alvira CM, Abate A, Yang G, Dennery PA, Rabinovitch M. Am J Respir Crit Care Med. 2007 Apr 15;175(8):805-15.

  4. Wnt5a is required for cardiac outflow tract septation in mice. Schleiffarth JR, Person AD, Martinsen BJ, Sukovich DJ, Neumann A, Baker CV, Lohr JL, Cornfield DN, Ekker SC, Petryk A. Pediatr Res. 2007 Apr;61(4):386-91.

May

  1. Idiopathic pulmonary hemosiderosis: clinical profile and follow up of 26 children. Kabra SK, Bhargava S, Lodha R, Satyavani A, Walia M. Indian Pediatr. 2007 May;44(5):333-8.

  2. Supine sleeping position does not cause clinical aspiration in neonates in hospital newborn nurseries. Tablizo MA, Jacinto P, Parsley D, Chen ML, Ramanathan R, Keens TG. Arch Pediatr Adolesc Med. 2007 May;161(5):507-10.

June

  1. Imaging of the chest in cystic fibrosis. Robinson TE. Clin Chest Med. 2007 Jun;28(2):405-21. Review.

  2. Nutrition and lung disease in cystic fibrosis. Milla CE. Clin Chest Med. 2007 Jun;28(2):319-30. Review.

July

  1. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss RB, Williams J, Ramsey BW. Pediatr Pulmonol. 2007 Jul;42(7):610-23.

  2. No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations. Clancy JP, Rowe SM, Bebok Z, Aitken ML, Gibson R, Zeitlin P, Berclaz P, Moss RB, Knowles MR, Oster RA, Mayer-Hamblett N, Ramsey B. Am J Respir Cell Mol Biol. 2007 Jul;37(1):57-66.

August

  1. A critical discussion of computer analysis in medical imaging. Goris ML, Zhu HJ, Robinson TE. Proc Am Thorac Soc. 2007 Aug 1;4(4):347-9. Review.

  2. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Robinson TE. Proc Am Thorac Soc. 2007 Aug 1;4(4):310-5. Review.

  3. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Moss RB, Milla CE, Colombo J, Accurso F, Zeitlin PL, Clancy JP, Spencer LT, Pilewski J, Waltz DA, Dorkin HL, Ferkol T, Pian M, Ramsey B, Carter BJ, Martin DB, Heald AE. Hum Gene Ther. 2007 Aug;18(8):726-32.

September

  1. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, Lee AB, Blazar BR, Cornfield DN, Miller JS, Verneris MR. Blood. 2007 Sep 1;110(5):1530-9. Epub 2007 May 10.

October

  1. Comparison of high-frequency chest wall oscillation with differing waveforms for airway clearance in cystic fibrosis. Kempainen RR, Williams CB, Hazelwood A, Rubin BK, Milla CE. Chest. 2007 Oct;132(4):1227-32. Epub 2007 Sep 21.

November

  1. Developmental regulation of hypoxia-inducible factor 1 and prolyl-hydroxylases in pulmonary vascular smooth muscle cells. Resnik ER, Herron JM, Lyu SC, Cornfield DN. Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18789-94.

December

  1. Integrative medicine and asthma. Mark JD. Pediatr Clin North Am. 2007 Dec;54(6):1007-23; xii. Review.